Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?

Defining optimal adjuvant treatment for older women with breast cancer is challenged by the lack of level-1 clinical evidence and the heterogeneity of the older population. Nevertheless, recommendations based on reviews of available evidence mainly from retrospective subgroup analyses and extrapolat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mislang, Anna Rachelle, Biganzoli, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586766/
https://www.ncbi.nlm.nih.gov/pubmed/26151681
http://dx.doi.org/10.3390/cancers7030833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586766/
https://www.ncbi.nlm.nih.gov/pubmed/26151681
http://dx.doi.org/10.3390/cancers7030833

Ejemplares similares